Antioxidants and the mutagenicity of benzo(a) pyrene and some derivatives. 1978

L M Calle, and P D Sullivan, and M D Nettleman, and I J Ocasio, and J Blazyk, and J Jollick

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D001580 Benzopyrenes A class of chemicals that contain an anthracene ring with a naphthalene ring attached to it. Benzpyrene
D012486 Salmonella typhimurium A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER. Salmonella typhimurium LT2
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

L M Calle, and P D Sullivan, and M D Nettleman, and I J Ocasio, and J Blazyk, and J Jollick
January 1982, Mutation research,
L M Calle, and P D Sullivan, and M D Nettleman, and I J Ocasio, and J Blazyk, and J Jollick
November 1980, Cancer letters,
L M Calle, and P D Sullivan, and M D Nettleman, and I J Ocasio, and J Blazyk, and J Jollick
August 1987, Carcinogenesis,
L M Calle, and P D Sullivan, and M D Nettleman, and I J Ocasio, and J Blazyk, and J Jollick
May 1977, The Biochemical journal,
L M Calle, and P D Sullivan, and M D Nettleman, and I J Ocasio, and J Blazyk, and J Jollick
September 1976, Cancer research,
L M Calle, and P D Sullivan, and M D Nettleman, and I J Ocasio, and J Blazyk, and J Jollick
February 1987, Biochemical and biophysical research communications,
L M Calle, and P D Sullivan, and M D Nettleman, and I J Ocasio, and J Blazyk, and J Jollick
July 1983, Toxicology letters,
L M Calle, and P D Sullivan, and M D Nettleman, and I J Ocasio, and J Blazyk, and J Jollick
July 1986, Biochemical pharmacology,
L M Calle, and P D Sullivan, and M D Nettleman, and I J Ocasio, and J Blazyk, and J Jollick
July 1991, Carcinogenesis,
L M Calle, and P D Sullivan, and M D Nettleman, and I J Ocasio, and J Blazyk, and J Jollick
December 1972, British journal of cancer,
Copied contents to your clipboard!